ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Human bladder cancers and normal bladder mucosa present the same hot spot of heterozygous chromosome-9 deletion
Author(s): Baud E, Catilina P, Boiteux JP, Bignon YJ
Source: INTERNATIONAL JOURNAL OF CANCER    Volume: 77    Issue: 6    Pages: 821-824    Published: SEP 11 1998  
Times Cited: 33     References: 26     
Abstract: Loss of heterozygosity (LOH) on chromosome 9 is the most frequent genetic alteration in bladder cancer identified to date, suggesting the presence of key gene(s) for this pathology. In this study, we examined 44 bladder tumors and 21 normal bladder samples for LOH on both arms of chromosome 9. Sixteen microsatellite markers, 12 on the short arm (encompassing 9p21-22) and 4 on the long arm (encompassing 9q33-34), were chosen for their highly frequent alterations in bladder cancer. LOH for at lease one marker was identified in 42 tumor samples (95.5%), and 14 tumors (32%) displayed LOH for all informative tested markers. Detailed analysis showed that 2 markers on chromosome 9p (D9S157 and D9S156) had the highest frequencies of allelic loss (about 70%), independent of tumor grade and stage. The same study was performed on the 21 normal bladder mucosa samples: 50% of informative cases presented a single specific LOH at the D9S156 locus. Normal samples showing LOH at this locus were therefore screened with 3 never microsatellite markers in the 810-kb region incorporating D9S156. Using this marker, we found no further heterozygous loss in this region. This result allows different interpretations of the D9S156 loss in normal bladder mucosa, and suggests that D9Sr56 may be more an indicator of bladder epithelium impairment than a tumor-initiation marker. Similarly, this unexpected result calls in question the interpretation of LOH studies. (C) 1998 Wiley-Liss, Inc.
Document Type: Article
Language: English
Reprint Address: Bignon, YJ (reprint author), Ctr Jean Perrin, Oncol Mol Lab, INSERM, CRI9502,EA2145, 58 Rue Montalembert BP 392, F-63011 Clermont Ferrand, France
Addresses:
1. Ctr Jean Perrin, Oncol Mol Lab, INSERM, CRI9502,EA2145, F-63011 Clermont Ferrand, France
2. Fac Med, Inst Hyg & Med Travail, Clermont Ferrand, France
3. Ctr Hosp Reg Univ, Serv Urol, Clermont Ferrand, France
Publisher: WILEY-LISS, DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
Subject Category: Oncology
IDS Number: 110VG
ISSN: 0020-7136
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo